Vanderbilt-Ingram Cancer Center is “pushing the envelope” with new technologies like histotripsy and new programs like robotic liver surgery and robotic pancreas surgery, serving patients not only from Tennessee, but also parts of Kentucky, Alabama and Georgia.  

The study is still recruiting participants. It will conclude in 2026 and provide insight for further investigations into the role GLP-1 agonists may offer in treating respiratory illnesses and overall immune responses.

The Vanderbilt Center for Antibody Therapeutics has received large-scale government grants and contracts to fund the discovery of human antiviral antibodies. The problem is the next step — finding corporate partners to develop the antibodies through human testing.

Although Black and Hispanic people are more apt to have dementia, they are significantly less apt than other racial and ethnic groups to show Alzheimer's pathology on brain scans. 

Jean-Paul Marie, MD, PhD, a physician from France who has spent over two decades honing the selective laryngeal reinnervation, presented at the second annual Robert H. Ossoff Lecture and was a guest in the operating room for Vanderbilt Health’s seventh such surgery.

From thought-provoking lectures to data-driven presentations, Research Week provided a platform for researchers to share their discoveries, inspire collaboration and ignite new ideas to improve the lives of children everywhere. 

Ultrasound is easier on the brain, both physically and mentally. Reducing the burden for patients goes a long way toward a positive experience in the diagnosis and treatment process.